Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
(54 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
 
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
  
−
:Secretary: Julie Lisiecki
+
:RSNA Staff Support: Julie Lisiecki
 
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
 
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
  
Line 20: Line 20:
 
==PET Amyloid Meetings/Call Summaries==
 
==PET Amyloid Meetings/Call Summaries==
  
−
*[[Media:05_11_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|May 11, 2018]]
+
*[[Media:2022_05-20_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-DM-AMS.pdf|May 20, 2022]]
−
*[[Media:04_13_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL-dcm-esp.pdf|April 13, 2018]]
+
*[[Media:2022_04-15_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|April 15, 2022]]
−
*[[Media:03_09_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|March 9, 2018]]
+
*[[Media:2022_03-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 11, 2022]]
−
*[[Media:02_09_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL-dcm.pdf|February 9, 2018]]
+
*[[Media:2022_02-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 11, 2022]]
 +
*[[Media:2022_01-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|January 14, 2022]]
 +
 
  
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
  
 
==PET Amyloid Profile Development==
 
==PET Amyloid Profile Development==
 +
 +
Clean version of Technically Confirmed Profile for use! - also available on the Profiles {https://qibawiki.rsna.org/index.php/Profiles} page
 +
*[[Media:Supplement_QIBA_AmyloidPET_3Jun2022_TechnicallyConfirmed.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker-2022-06-03]] clean version
 +
 +
---------------------------------------------------------
 +
Redlined version of Technically Confirmed Profile - showing comments addressed:
 +
*[[Media:QIBA_AmyloidPET_1Jun2022_TechnicallyConfirmed edits redlined.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker-2022-06-01]] edits redlined
 +
 +
---------------------------------------------------------
 +
For NM CC vote - Technically Confirmed:
 +
 +
*[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-clean.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(clean version)-2022-04-14]]
 +
*[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-redline.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(marked up version)-2022-04-14]]
 +
*[[Media:QIBA_PET Amyloid_Profile_Updates_15April2022.pdf | Profile Updates Summary-2022-04-15]]
 +
----------------------------------------------------------
 +
*[[Media:QIBA AmyloidPET 20June2018 consensus.pdf| PET F-18 for Amyloid 2018-06-20]] - Consensus Profile
  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
Line 56: Line 74:
 
==Presentations and Reports==
 
==Presentations and Reports==
  
 +
*[[Media:08Jun2018_BCMeeting_Amyloid_updated.pdf | 06 08 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 
*[[Media:11May2018_BCMeeting_Amyloid_updated.pdf | 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 
*[[Media:11May2018_BCMeeting_Amyloid_updated.pdf | 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 
*[[Media:13April2018_BCMeeting_Amyloid.pdf | 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 
*[[Media:13April2018_BCMeeting_Amyloid.pdf | 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
Line 76: Line 95:
  
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 +
 +
==QIBA Funded Projects==
 +
 +
====Round 4====
 +
*[[Media:Amyloid Profile Continued Support with Brain Phantom Development.pdf | Project (X) Amyloid Profile Continued Support with Brain Phantom Development (University of Iowa)]]
 +
 +
====Round 5====
 +
*[[Media:Analyses to Support Amyloid Imaging Profile Development.pdf | Project (A) Analyses to Support Amyloid Imaging Profile Development (ADM Diagnostics, LLC)]]
 +
 +
*[[Media:Amyloid Brain PET Test-Retest Meta-analysis.pdf | Project (E) Amyloid Brain PET Test-Retest Meta-analysis (Johns Hopkins University)]]
 +
 +
*[[Media:A PET-Metabolic Tumor Volume-DRO.pdf | Project (I) A PET-Metabolic Tumor Volume-Digital Reference Object (PET-MTV-DRO) (University of Washington)]]
 +
 +
*[[Media:A Procedure to Facilitate Greater Standardization of PET Spatial Resolution.pdf | Project (J) A Procedure to Facilitate Greater Standardization of PET Spatial Resolution (Johns Hopkins University)]]

Revision as of 23:18, 3 June 2022

Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
RSNA Staff Support: Julie Lisiecki


Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries


PET Amyloid BC Call Summaries Archive

PET Amyloid Profile Development

Clean version of Technically Confirmed Profile for use! - also available on the Profiles {https://qibawiki.rsna.org/index.php/Profiles} page

Redlined version of Technically Confirmed Profile - showing comments addressed:

For NM CC vote - Technically Confirmed:

Profile Supporting Material

Working Documents

Presentations and Reports

QIBA Funded Projects

Round 4

Round 5

Retrieved from "https://qibawiki.rsna.org/index.php?title=PET_Amyloid_Biomarker_Ctte&oldid=18300"